Match tier
Likely match
Presence
Current · Arkansas
Last published
2024
Sources
OpenAlex · ORCID
Refreshed
2026-08-08
G
Gabriel Gifford
This is a likely match — the affiliation was inferred from OpenAlex, ORCID, and web sources but has not been fully confirmed. Treat with appropriate caution.
Researcher
Graduate Student Researcher
1 pubs
Research Areas
Biography and Research Information
OverviewAI-generated summary
Gabriel Gifford's research focuses on the evaluation of disquaramide compounds as potential anti-leishmanial drugs. His work involves synthesis and in vitro testing to assess the efficacy of these compounds against leishmaniasis, a parasitic disease. Gifford has one publication detailing these findings, which was published in 2024. His collaborative network includes researchers from the University of Arkansas for Medical Sciences, such as Karl W. Boehme, Alexx Weaver, and Tiffany Weinkopff, as well as Gregory R. Naumiec from the University of Central Arkansas. These collaborations have resulted in shared publications, indicating active engagement within the research community.
Metrics
- Publications: 1
Selected Publications
-
Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs (2024)
Collaboration Network
Top Collaborators
Hayden Roys
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Assyl Arykbayeva
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Sarah K. Friedman
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Eva R. Palmer
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Alex Rogers
University of Central Arkansas (US)
1 shared publication
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Emily N. H. Tran
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Lucy Fry
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Alexx Weaver
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Anne K. Bowlin
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Meghan D. Jones
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Michael R. Eledge
University of Arkansas for Medical Sciences (US)
1 shared publication
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Karl W. Boehme
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Gregory R. Naumiec
University of Central Arkansas
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Tiffany Weinkopff
University of Arkansas for Medical Sciences
1 shared publication
In database
- Synthesis and in vitro evaluation shows disquaramide compounds are a promising class of anti-leishmanial drugs
Similar Researchers
Based on overlapping research topics
Mary Alice Smith
National Center for Toxicological Research
Microbial infections and disease research
Disease Models, Animal
Host-Pathogen Interactions
Alison Gouch
University of Arkansas for Medical Sciences
Microbial infections and disease research
Disease Models, Animal
Host-Pathogen Interactions
Rokeya Akter
University of Arkansas at Fayetteville
Microbial infections and disease research
Disease Models, Animal
Host-Pathogen Interactions
Zoya Faruqui
University of Arkansas at Little Rock
Microbial infections and disease research
Disease Models, Animal
Host-Pathogen Interactions
Elizabeth Keifer
University of Arkansas at Fayetteville
Microbial infections and disease research
Host-Pathogen Interactions
Health and Medical Research Impacts
Rosalind R. White
University of Arkansas for Medical Sciences
Microbial infections and disease research
Host-Pathogen Interactions
Health and Medical Research Impacts